Veterinary Implant Devices Market
Veterinary Implants Devices Market by Type (Orthopedic, Cardiovascular, Active Electronic, Drug Delivery), Application (Health Monitoring, Treatment Management), Animal (Companion, Livestock, Performance), End User (Hospitals) - Global Forecast to 2031
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The veterinary implant devices market is projected to reach USD 0.98 billion by 2031 from USD 0.74 billion in 2026, growing at a CAGR of 5.7% during the forecast period. The market is driven by the growing number of veterinary procedures requiring implantable solutions, particularly among companion animals. Increasing prevalence of orthopedic injuries, degenerative diseases, urinary disorders, and cardiovascular conditions is encouraging veterinarians and animal owners to pursue surgical and interventional treatments that incorporate implants. Beyond companion animals, demand from livestock, performance animals, wildlife, and research animals is broadening the market base. Livestock producers are increasingly using implantable identification and monitoring technologies to support herd management, while research institutions are adopting implantable telemetry and sensing devices for continuous physiological monitoring. At the same time, improvements in veterinary specialty services, greater availability of trained veterinary surgeons, and rising investment in animal healthcare infrastructure are increasing access to implant-based procedures across key markets.
KEY TAKEAWAYS
-
By RegionBy region, North America accounted for a 33.9% share of the global veterinary implant devices market in 2025.
-
By Implant DeviceBy implant device, the monitoring, sensing, and diagnostic implants segment is expected to register a CAGR of 6.8% between 2026 and 2031.
-
By Animal TypeBy animal type, the companion animals segment held the largest share of the global veterinary implant devices market in 2025.
-
By ApplicationBy application, the activity, behavior, and performance enhancement segment is anticipated to exhibit a CAGR of 7.6% during the forecast period.
-
By End UserBy end user, the veterinary clinics and hospitals segment captured a 55.6% market share in 2025.
-
Competitive Landscape - CRO Key PlayersMerck & Co., Inc. (US), Elanco (US), Johnson & Johnson (DePuy Synthes) (US), Zoetis Inc (US), Virbac (France), B. Braun SE (Germany), Harvard Biosciences. Inc (Data Science International) (US), Securos Surgical (Cencora, Inc) (US), BioMedtrix, LLC (US), IMEX Veterinary, Inc (Movora) (US), KYON (Movora)(Switzerland), New Generation Devices (NGD)(US), Veterinary Orthopedic Implants (US), Arthrex, Inc (Arthrex Vet Systems) (US), and Infiniti Medical, LLC (US) were identified as some of the star players in the veterinary implant devices market, given their extensive global reach and comprehensive service portfolios.
-
Competitive Landscape - CRO StartupsPH Orthcom (China), Veterinary Instrumentation (UK), Star Oddi (Iceland), Biotronik (Germany), Thema Biotel (Norway), SmaXtec Animal Care Gmbh (Austria), Auxilium MD (Teliatry, Inc.) (US), Biovetsensor (France), Norfolk Vet products (US), and Primetech Corporation (Japan). These companies strengthen their competitive positions by developing specialized veterinary implants, procedure-specific orthopedic and interventional devices, implantable monitoring and sensing technologies, and customized solutions addressing the needs of companion animals, livestock, research institutions, and other specialized veterinary applications.
The global veterinary implant devices market is driven by the increasing adoption of advanced veterinary procedures, rising animal healthcare expenditure, and growing use of implants for orthopedic, cardiovascular, urinary, reproductive, therapeutic, and monitoring applications. Expanding veterinary specialty care and livestock health management are further increasing implant utilization. Advances in 3D-printed, minimally invasive, patient-specific, and wireless implant technologies are improving treatment precision and monitoring capabilities, supporting broader adoption of veterinary implant devices.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
Major trends and disruptions shaped the veterinary implant devices market in 2025, driven by increasing adoption of patient-specific implants, minimally invasive procedures, advanced biomaterials, and implantable monitoring technologies. Expanding applications across companion-animal orthopedics, cardiovascular and interventional procedures, urinary and soft-tissue applications, livestock production, veterinary research, and wildlife monitoring are creating new opportunities, particularly in improved surgical outcomes, continuous animal monitoring, and species-specific treatment. Meanwhile, three-dimensional (3D) printing, artificial intelligence (AI)-enabled surgical planning, wireless telemetry, smart implants, implantable sensors, and digital animal-health platforms are improving implant selection, surgical precision, physiological monitoring, and clinical decision-making. Growing demand for personalized veterinary care, reduced procedure-related complications, continuous animal-health monitoring, and improved research efficiency is also accelerating the development of customized implants, connected monitoring systems, advanced cardiovascular devices, and specialized solutions for livestock, wildlife, and research applications. These developments are shifting the market toward new technologies, products, applications, integrated digital solutions, and specialized veterinary ecosystems.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Level
-
Rising pet ownership and increasing humanization of companion animals

-
Increasing prevalence of diseases and disorders
Level
-
High cost of veterinary implant procedures and devices
-
Shortage of trained veterinary surgeons specialized in implant-based procedures
Level
-
Increasing development of 3D-printed, patient-specific veterinary implants and digital surgical planning
-
Expansion of veterinary implant applications in livestock and aquatic animals
Level
-
Clinical complications associated with veterinary implant devices
-
Regulatory and quality compliance complexity for veterinary implant devices
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Rising pet ownership and increasing humanization of companion animals
The growing adoption of pets and increasing humanization of companion animals are driving the demand for veterinary implant devices, particularly across orthopedic, therapeutic, cardiovascular, soft-tissue, and monitoring applications. As pet owners increasingly consider companion animals as family members, spending on advanced veterinary care is rising, including treatments for fractures, joint disorders, ligament injuries, cardiovascular conditions, and chronic diseases. Greater emphasis on improving animal longevity, mobility, quality of life, and recovery is encouraging the adoption of fracture fixation systems, joint replacements, TPLO/TTA implants, implantable drug-delivery systems, cardiac devices, and monitoring implants, supporting continued expansion of the companion animal veterinary implant market.
Restraint: High cost of veterinary implant procedures and devices
The high cost of veterinary implant devices and associated surgical procedures can limit their adoption, particularly for companion animals, where treatment expenses are often borne directly by pet owners. The total cost can include the implant, diagnostic imaging, anesthesia, surgery, hospitalization, and post-operative care, while advanced procedures may also require specialized equipment and trained veterinary surgeons. Limited pet insurance coverage and high out-of-pocket expenses can make advanced implant procedures less affordable, leading some owners to delay treatment or choose lower-cost alternatives, thereby constraining the adoption of high-value veterinary implant devices.
Opportunity: Increasing development of 3D-printed, patient-specific veterinary implants and digital surgical planning
The increasing development of 3D-printed, patient-specific veterinary implants and digital surgical planning is creating opportunities for manufacturers to provide customized solutions for complex orthopedic and skeletal procedures. 3D printing enables implants to be designed according to an animal’s individual anatomy, supporting improved fit and procedure-specific designs for fracture fixation, bone reconstruction, joint replacement, and other complex surgeries. Digital imaging, 3D anatomical modeling, virtual surgical planning, and computer-assisted procedures further enable veterinarians to evaluate anatomy and plan implant placement before surgery. The growing availability of advanced imaging and additive manufacturing technologies is expected to support the development of customized implants and expand the use of personalized veterinary implant solutions.
Challenge: Clinical complications associated with veterinary implant devices
The risk of clinical complications remains a key challenge in the adoption of veterinary implant devices, particularly across orthopedic, cardiovascular, urinary, and other invasive applications. Complications such as infection, inflammation, implant migration or loosening, tissue damage, fracture, rejection, and inadequate healing can occur depending on the implant type, surgical technique, animal condition, and post-operative care. These complications may require additional procedures, implant revision or removal, and extended treatment, increasing the overall cost and clinical burden. Differences in animal anatomy, physiology, activity levels, and healing responses further complicate the prediction of implant performance, requiring appropriate implant selection, surgical expertise, post-operative monitoring, and follow-up care.
VETERINARY IMPLANT DEVICES MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
|
|
Enables controlled delivery of growth-promoting hormones through veterinary cattle implants, including the Synovex portfolio, across different stages of beef production | Supports improved weight gain, feed efficiency, and production performance through sustained implant-based hormone delivery |
|
|
Provides sustained-release veterinary implants, including Suprelorin, for controlled hormonal and reproductive management in dogs and ferrets | Enables reversible and long-duration reproductive management while reducing the need for repeated treatments or surgical intervention |
|
|
Develops veterinary orthopedic implant systems, including total hip replacement, knee, elbow, and fracture fixation systems, designed for companion-animal orthopedic procedures | Improves joint reconstruction, skeletal stabilization, and mobility in dogs and other companion animals while supporting treatment of complex orthopedic conditions |
|
|
Develops growth-promoting implant technologies, including Revalor implants, for controlled hormone delivery in beef cattle | Improves cattle growth and feed efficiency while supporting production-performance management across different livestock production stages |
|
|
Develops veterinary orthopedic implant systems, including plates, screws, fracture-fixation systems, and TPLO/TTA solutions for companion animals | IImproves cattle growth and feed efficiency while supporting production-performance management across different livestock production stages |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The veterinary implant devices market forms an ecosystem comprising veterinary implant product manufacturers, animal health companies, veterinary hospitals and clinics, research and academic institutions, and regulatory bodies. Key manufacturers and animal health companies such as Zoetis Inc., BioMedtrix, DePuy Synthes, Securos Surgical, Virbac, and Merck provide orthopedic, therapeutic, reproductive, growth-promoting, identification, monitoring, and other veterinary implant solutions. End users include veterinary clinics and hospitals such as VCA and Ringpai Pet Hospital, as well as research and academic institutions such as the Indian Veterinary Research Institute and Iowa State University College of Veterinary Medicine. Regulatory stakeholders, including the US Food and Drug Administration (FDA), European Medicines Agency (EMA), Australian Pesticides and Veterinary Medicines Authority (APVMA), and Ministry of Agriculture and Rural Affairs of the People's Republic of China, establish requirements governing veterinary products and animal health applications. The ecosystem is further supported by veterinary professionals, livestock operations, pharmaceutical and biotechnology companies, and research organizations, driving the development and adoption of advanced implants focused on animal health, treatment outcomes, monitoring, recovery, and long-term care.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Veterinary Implant Devices Market, By Implant Device
In 2025, orthopedic and skeletal implants held the largest share of the veterinary implant devices market. The segment benefits from the wide range of implant systems used to manage musculoskeletal conditions in companion animals, including fracture fixation plates, screws, pins, joint replacement systems, and TPLO/TTA implants. Growing adoption of specialized orthopedic procedures, improvements in implant design and fixation techniques, and increasing demand for durable, biocompatible implants are supporting the segment. The increasing availability of veterinary orthopedic specialists and advanced surgical facilities is further expanding the use of these devices.
Veterinary Implant Devices Market, By Application
In 2025, orthopedic and fracture repair accounted for the largest share of the veterinary implant devices market. The application covers a range of procedures performed to restore bone stability and mobility following traumatic fractures, cranial cruciate ligament injuries, joint damage, and other musculoskeletal disorders. Rising incidence of orthopedic conditions in companion animals, greater diagnosis of injuries through advanced imaging, and increasing acceptance of surgical intervention are driving procedure volumes. The growing use of minimally invasive and advanced fixation techniques is also supporting demand for implant-based fracture repair.
Veterinary Implant Devices Market, By End User
In 2025, veterinary clinics and hospitals captured the largest share of the veterinary implant devices market. These facilities account for a substantial proportion of implant procedures because they provide the diagnostic, surgical, anesthesia, imaging, and postoperative care required for implant placement. The expansion of specialty and referral hospitals, increasing availability of veterinary orthopedic and surgical specialists, and investment in advanced operating and diagnostic infrastructure are enabling clinics and hospitals to perform more complex implant-based procedures. Their role across multiple implant applications, including orthopedic, cardiovascular, urinary, and soft-tissue procedures, further supports their leading market position.
REGION
Asia Pacific to be fastest-growing region in global veterinary implant devices market during forecast period
During the forecast period, Asia Pacific is expected to register the highest CAGR in the veterinary implant devices market. The region's growth is mainly driven by rising pet ownership, increasing expenditure on animal healthcare, expansion of specialty veterinary hospitals, and growing adoption of advanced orthopedic and surgical procedures in countries such as China, Japan, India, Australia, and South Korea, particularly for fracture fixation, cranial cruciate ligament repair, TPLO, TTA, and joint replacement procedures. Rising pet healthcare expenditure and the expansion of specialty veterinary hospitals are increasing access to these procedures, while improvements in diagnostic imaging and surgical capabilities are enabling more complex implant-based interventions. In parallel, the region's substantial livestock population supports demand for production implants, reproductive implants, identification technologies, and intraruminal and physiological monitoring devices, particularly as commercial livestock operations adopt more data-driven animal-health and production-management practices. The combination of expanding companion-animal specialty care, large-scale livestock production, and improving veterinary infrastructure is expected to accelerate adoption of veterinary implant devices across the region.

VETERINARY IMPLANT DEVICES MARKET: COMPANY EVALUATION MATRIX
Merck & Co., Inc. emerges as a prominent player in the veterinary implant devices market, supported by its broad animal health portfolio, established livestock presence, and expertise in implant-based production and animal identification technologies. Through Merck Animal Health, the company serves livestock and companion-animal markets, with veterinary implants primarily used in cattle production and animal identification and monitoring applications. Merck's position is supported by its revalor cattle implant portfolio. The company's strong position is further supported by its established global commercial infrastructure, extensive livestock customer base, and integration of animal health, production, identification, and monitoring technologies. Merck Animal Health's ability to provide products addressing cattle growth performance strengthens its product footprint across livestock applications. Its established relationships with veterinarians, livestock producers, and animal-health professionals, combined with continued investment in animal health technologies, support its market presence and provide opportunities for further expansion in the veterinary implant devices market. BioMedtrix (US) is a recognized player in the veterinary implant devices market, specializing in orthopedic implants for companion animals. Its portfolio includes hip replacement systems (BFX and CFX), TPLO bone plates, and I-Loc intramedullary fixation systems for treating orthopedic conditions and fractures. The TPLO Curve plate features a silver-based antimicrobial HyProtect coating designed to provide localized infection protection. Through continued product innovation and a specialized focus on companion-animal orthopedics, the company contributes to the advancement of veterinary implant solutions.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- Merck & Co., Inc (US)
- Elanco (US)
- Johnson & Johnson (Depuy synthes) (US)
- Zoetis Inc (US)
- Virbac (France)
- B.Braun SE (US)
- Hardvard Biosciences Inc (Data Science International) (US)
- Securos Surgical (Cencora, Inc) (US)
- Biomedtrix, LLC (Movora) (US)
- IMEX Veterinary, Inc (Movora) (US)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2025 (Value) | USD 0.71 BN |
| Market Size in 2026 (Value) | USD 0.74 BN |
| Market Forecast in 2031 (Value) | USD 0.98 BN |
| Growth Rate | CAGR of 5.7% from 2026-2031 |
| Years Considered | 2024-2031 |
| Base Year | 2025 |
| Forecast Period | 2026-2031 |
| Units Considered | Value (USD Million/Billion), Volume (Thousand/Million Units) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered |
|
| Regions Covered | North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
WHAT IS IN IT FOR YOU: VETERINARY IMPLANT DEVICES MARKET REPORT CONTENT GUIDE

DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Product Analysis | Compared key veterinary implant categories, including orthopedic and skeletal, cardiovascular and interventional, urinary and soft-tissue, active electronic, therapeutic/drug-delivery, and monitoring/sensing implants. Evaluated product types, implant materials, fixation technologies, species suitability, procedure applications, clinical requirements, implantation methods, technology maturity, and adoption trends across companion animals, livestock, research, and wildlife applications. | Enabled identification of suitable implant technologies, product specifications, clinical requirements, and application benchmarks. Supported decisions related to product portfolio development, technology selection, implant design, product differentiation, and expansion into emerging veterinary applications. |
| Company Information | Profiled major players including Merck & Co., Inc., Elanco, Johnson & Johnson (DePuy Synthes Vet), Zoetis, Virbac, B. Braun, Harvard Bioscience (Data Sciences International), Securos Surgical, BioMedtrix, IMEX Veterinary, KYON, New Generation Devices (NGD), Veterinary Orthopedic Implants, Arthrex Vet Systems, and Infiniti Medical. Provided insights into product portfolios, implant technologies, manufacturing capabilities, application focus, geographic presence, partnerships, acquisitions, R&D activities, and competitive positioning. | Provided clarity on competitive positioning, product differentiation, manufacturing capabilities, application expertise, R&D strengths, geographic expansion, and strategic priorities. Supported evaluation of potential technology partners, suppliers, distributors, acquisition targets, and collaboration opportunities across veterinary implant applications. |
| Geographic Analysis | Provided region-by-region analysis of veterinary implant adoption across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, including pet healthcare expenditure, veterinary infrastructure, specialty hospital development, livestock production, implant adoption trends, regulatory environment, clinical capabilities, and investment opportunities. | Supported global strategy planning by identifying regional growth opportunities for veterinary implant devices. Helped evaluate market maturity, regulatory requirements, specialist availability, local manufacturing and distribution opportunities, and potential regions for capacity expansion, partnerships, and market entry. |
RECENT DEVELOPMENTS
- May 2026 : Zoetis received expanded US approval for Synovex one grower, extending its use to increase the rate of weight gain in growing beef steers and heifers in dry lots or on pasture with insufficient forage.
- April 2026 : Arthrex Vet Systems highlighted the use of its OrthoLine distal femur osteotomy system, including plates and screws, to support surgical treatment of a dog with complex femoral fractures, demonstrating the application of its veterinary orthopedic implant portfolio in complex fracture repair.
- July 2025 : Virbac received marketing authorization in Japan for Suprelorin (deslorelin acetate) implant, expanding availability of its reversible, minimally invasive reproductive-management implant for companion animals.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Personalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Veterinary Implants Devices Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free CustomisationTESTIMONIALS

Growth opportunities and latent adjacency in Veterinary Implants Devices Market